Cargando…

RTS,S/AS01 Malaria Vaccine - The Next Step for a Developing Country

Detalles Bibliográficos
Autores principales:	ZEHRA, ASMAT, SYED, BUSHRA, MASOOD, FAREEHA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore Srl 2022
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121669/ https://www.ncbi.nlm.nih.gov/pubmed/35647385 http://dx.doi.org/10.15167/2421-4248/jpmh2022.63.1.2379

Ejemplares similares

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
por: Fortpied, Juliette, et al.
Publicado: (2020)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan
por: Gosling, Roly, et al.
Publicado: (2016)

RTS,S/AS01 malaria vaccine (Mosquirix(®)): a profile of its use
por: Syed, Yahiya Y.
Publicado: (2022)

Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report
por: Merle, Corinne S.
Publicado: (2023)

Should India be considering deployment of the first malaria vaccine RTS, S/AS01?
por: Rahi, Manju, et al.
Publicado: (2022)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
por: Bell, Griffin J., et al.
Publicado: (2020)

Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
por: Arora, Navneet, et al.
Publicado: (2021)

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
por: Mumtaz, Hassan, et al.
Publicado: (2023)

Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
por: Nadeem, Aroosa Younis, et al.
Publicado: (2022)

Cost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program
por: Baral, Ranju, et al.
Publicado: (2023)

Simulated Impact of RTS,S/AS01 Vaccination Programs in the Context of Changing Malaria Transmission
por: Brooks, Alan, et al.
Publicado: (2012)

Impacts of Ecology, Parasite Antigenic Variation, and Human Genetics on RTS,S/AS01e Malaria Vaccine Efficacy
por: Bell, Griffin J., et al.
Publicado: (2021)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
por: Polhemus, Mark E., et al.
Publicado: (2009)

The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01(E) Malaria Vaccine( )
por: Sagara, Issaka, et al.
Publicado: (2021)

RTS,S: the first malaria vaccine
por: Zavala, Fidel
Publicado: (2022)

T Cell Responses to the RTS,S/AS01(E) and RTS,S/AS02(D) Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children
por: Ansong, Daniel, et al.
Publicado: (2011)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial
por: Waitumbi, John N., et al.
Publicado: (2009)

Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
por: Owusu-Agyei, Seth, et al.
Publicado: (2009)

The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity
por: Chaudhury, Sidhartha, et al.
Publicado: (2016)

Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status
por: Gyaase, Stephaney, et al.
Publicado: (2021)

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01(E) and RTS,S/AS01(B) Delayed Fractional Dose Regimens in Malaria-Naive Adults
por: Moon, James E, et al.
Publicado: (2020)

The Clinical Profile of Severe Pediatric Malaria in an Area Targeted for Routine RTS,S/AS01 Malaria Vaccination in Western Kenya
por: Akech, Samuel, et al.
Publicado: (2020)

Correction: Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
por: Owusu-Agyei, Seth, et al.
Publicado: (2010)

Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine
por: Swysen, Christine, et al.
Publicado: (2011)

Hepatitis A vaccination in developing countries: Is Syria next?
por: Habboub, Ghaith, et al.
Publicado: (2012)

Cost of introducing and delivering malaria vaccine (RTS, S/AS01(E)) in areas of seasonal malaria transmission, Mali and Burkina Faso
por: Diawara, Halimatou, et al.
Publicado: (2023)

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case–control study
por: Moncunill, Gemma, et al.
Publicado: (2022)

Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
por: Dobaño, Carlota, et al.
Publicado: (2019)

Protective antibody threshold of RTS,S/AS01 malaria vaccine correlates antigen and adjuvant dose in mouse model
por: Genito, Christopher J., et al.
Publicado: (2023)

The Costs of Implementing Vaccination With the RTS,S Malaria Vaccine in Five Sub-Saharan African Countries
por: Sicuri, Elisa, et al.
Publicado: (2019)

RTS,S Malaria Vaccine and Increased Mortality in Girls
por: Klein, Sabra L., et al.
Publicado: (2016)

Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries
por: Baral, Ranju, et al.
Publicado: (2021)

Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01(E) on Blood Stage Immunity in Young Children
por: Bejon, Philip, et al.
Publicado: (2011)

Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children
por: Lusingu, John, et al.
Publicado: (2010)

Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study
por: Hogan, Alexandra B., et al.
Publicado: (2020)

Ad35.CS.01 - RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults
por: Ockenhouse, Christian F., et al.
Publicado: (2015)

Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01(E) vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention
por: Chandramohan, Daniel, et al.
Publicado: (2020)

Correction: Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries
por: Baral, Ranju, et al.
Publicado: (2021)

Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01(E) and Protection against P falciparum Clinical Malaria
por: Olotu, Ally, et al.
Publicado: (2011)

A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon
por: Lell, Bertrand, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_buj4nvipcqlqp06pjqga1vv8j3